Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Using Diffusion-Weighted MRI to Predict Aggressive Histological Features in Papillary Thyroid Carcinoma: A Novel Tool for Pre-Operative Risk Stratification in Thyroid Cancer.

Lu Y, Moreira AL, Hatzoglou V, Stambuk HE, Gonen M, Mazaheri Y, Deasy JO, Shaha AR, Tuttle RM, Shukla-Dave A.

Thyroid. 2015 Apr 21. [Epub ahead of print]

PMID:
25809949
2.

Repeatability Investigation of Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging on Thyroid Glands.

Lu Y, Hatzoglou V, Banerjee S, Stambuk HE, Gonen M, Shankaranarayanan A, Mazaheri Y, Deasy JO, Shaha AR, Tuttle RM, Shukla-Dave A.

J Comput Assist Tomogr. 2015 Feb 13. [Epub ahead of print]

PMID:
25700226
3.

Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging.

Matulewicz L, Jansen JF, Bokacheva L, Vargas HA, Akin O, Fine SW, Shukla-Dave A, Eastham JA, Hricak H, Koutcher JA, Zakian KL.

J Magn Reson Imaging. 2014 Dec;40(6):1414-21. doi: 10.1002/jmri.24487. Epub 2013 Nov 15.

PMID:
24243554
4.

Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.

Arias-Mendoza F, Payne GS, Zakian K, Stubbs M, O'Connor OA, Mojahed H, Smith MR, Schwarz AJ, Shukla-Dave A, Howe F, Poptani H, Lee SC, Pettengel R, Schuster SJ, Cunningham D, Heerschap A, Glickson JD, Griffiths JR, Koutcher JA, Leach MO, Brown TR.

Acad Radiol. 2013 Sep;20(9):1122-9. doi: 10.1016/j.acra.2013.04.013.

5.

Diffusion-weighted MRI of the prostate at 3.0 T: comparison of endorectal coil (ERC) MRI and phased-array coil (PAC) MRI-The impact of SNR on ADC measurement.

Mazaheri Y, Vargas HA, Nyman G, Shukla-Dave A, Akin O, Hricak H.

Eur J Radiol. 2013 Oct;82(10):e515-20. doi: 10.1016/j.ejrad.2013.04.041. Epub 2013 Jun 28.

PMID:
23810189
6.

Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: a preliminary experience.

Lu Y, Jansen JF, Stambuk HE, Gupta G, Lee N, Gonen M, Moreira A, Mazaheri Y, Patel SG, Deasy JO, Shah JP, Shukla-Dave A.

J Comput Assist Tomogr. 2013 May-Jun;37(3):346-52. doi: 10.1097/RCT.0b013e318282d935.

7.

Role of MRI in prostate cancer detection.

Shukla-Dave A, Hricak H.

NMR Biomed. 2014 Jan;27(1):16-24. doi: 10.1002/nbm.2934. Epub 2013 Mar 13. Review.

PMID:
23495081
8.

Diffusion-weighted magnetic resonance imaging of the prostate: improved robustness with stretched exponential modeling.

Mazaheri Y, Afaq A, Rowe DB, Lu Y, Shukla-Dave A, Grover J.

J Comput Assist Tomogr. 2012 Nov-Dec;36(6):695-703. doi: 10.1097/RCT.0b013e31826bdbbd.

PMID:
23192207
9.

Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.

Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, Shukla-Dave A, Eastham J, Scardino P, Hricak H.

J Urol. 2012 Nov;188(5):1732-8. doi: 10.1016/j.juro.2012.07.024. Epub 2012 Sep 25.

PMID:
23017866
10.

Motion correction of multi-b-value diffusion-weighted imaging in the liver.

Mazaheri Y, Do RK, Shukla-Dave A, Deasy JO, Lu Y, Akin O.

Acad Radiol. 2012 Dec;19(12):1573-80. doi: 10.1016/j.acra.2012.07.005. Epub 2012 Sep 8.

PMID:
22963726
11.

Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS study.

Qi J, Fong Y, Saltz L, D'Angelica MI, Kemeny NE, Gonen M, Shia J, Shukla-Dave A, Jarnagin WR, Do RK, Schwartz LH, Koutcher JA, Zakian KL.

NMR Biomed. 2013 Feb;26(2):204-12. doi: 10.1002/nbm.2837. Epub 2012 Sep 7. Erratum in: NMR Biomed. 2014 Feb;27(2):235. Jarnagin, William M [corrected to Jarnagin, William R].

12.

Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.

Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J, Kanao K, Goldman DA, Moskowitz CS, Reuter VE, Eastham JA, Scardino PT, Hricak H.

Radiology. 2012 Nov;265(2):478-87. doi: 10.1148/radiol.12120041. Epub 2012 Sep 5.

13.

The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience.

Wassberg C, Akin O, Vargas HA, Shukla-Dave A, Zhang J, Hricak H.

AJR Am J Roentgenol. 2012 Aug;199(2):360-6. doi: 10.2214/AJR.11.6923.

14.

Extension of the intravoxel incoherent motion model to non-gaussian diffusion in head and neck cancer.

Lu Y, Jansen JF, Mazaheri Y, Stambuk HE, Koutcher JA, Shukla-Dave A.

J Magn Reson Imaging. 2012 Nov;36(5):1088-96. doi: 10.1002/jmri.23770. Epub 2012 Jul 23.

15.

Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.

Jansen JF, Carlson DL, Lu Y, Stambuk HE, Moreira AL, Singh B, Patel SG, Kraus DH, Wong RJ, Shaha AR, Shah JP, Shukla-Dave A.

Oral Oncol. 2012 Aug;48(8):717-22. doi: 10.1016/j.oraloncology.2012.02.001. Epub 2012 Feb 25.

16.

Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.

Shukla-Dave A, Hricak H, Akin O, Yu C, Zakian KL, Udo K, Scardino PT, Eastham J, Kattan MW.

BJU Int. 2012 May;109(9):1315-22. doi: 10.1111/j.1464-410X.2011.10612.x. Epub 2011 Sep 20.

17.

31P MR spectroscopic imaging detects regenerative changes in human liver stimulated by portal vein embolization.

Qi J, Shukla-Dave A, Fong Y, Gönen M, Schwartz LH, Jarnagin WM, Koutcher JA, Zakian KL.

J Magn Reson Imaging. 2011 Aug;34(2):336-44. doi: 10.1002/jmri.22616.

18.

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S, Wang Y, Kraus D, Shah JP, Pfister DG, Koutcher JA.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006. Epub 2011 May 19.

19.

MRI of the prostate: clinical relevance and emerging applications.

Mazaheri Y, Shukla-Dave A, Muellner A, Hricak H.

J Magn Reson Imaging. 2011 Feb;33(2):258-74. doi: 10.1002/jmri.22420. Review.

PMID:
21274967
20.

Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.

Jansen JF, Schöder H, Lee NY, Stambuk HE, Wang Y, Fury MG, Patel SG, Pfister DG, Shah JP, Koutcher JA, Shukla-Dave A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):299-307. doi: 10.1016/j.ijrobp.2010.11.022. Epub 2011 Jan 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk